Safety concerns linked to herbal medicine use in cancer

Safety concerns linked to herbal medicine use in cancer

(HealthDay)—For patients with cancer, use of herbal medicine has associated safety-related concerns, including direct toxic effects and increased chemosensitivity of cancer cells, according to a study published online Nov. 24 in Cancer.

Eran Ben-Arye, M.D., from the Lin Medical Center in Haifa, Israel, and colleagues examined the use of by Middle Eastern patients with , using a 17-item questionnaire that was administered by oncology health care professionals (HCPs). The literature was reviewed to assess potential negative effects associated with identified by the study HCPs.

The researchers found that 44 herbal and three non-herbal nutritional supplements were identified by 339 HCPs who completed the study questionnaire (response rate, 80.3 percent). Twenty-nine products had associated safety-related concerns, including herb-drug interactions with altered pharmacodynamics, direct toxic effects, and increased in vitro response of to chemotherapy (15, 18, and seven herbs, respectively).

"Oncology HCPs working in countries in which herbal medicine use is prevalent need to better understand the implications of this practice," the authors write. "The presence of integrative physicians with training in complementary and traditional medicine can help patients and their HCPs reach an informed decision regarding the safety and effective use of these products."


Explore further

Study finds physicians need to better recognize use of herbal supplements while breastfeeding

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Cancer

Copyright © 2015 HealthDay. All rights reserved.

Citation: Safety concerns linked to herbal medicine use in cancer (2015, December 2) retrieved 25 September 2020 from https://medicalxpress.com/news/2015-12-safety-linked-herbal-medicine-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments